AJP - Lung AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol (December 9, 2005). doi:10.1152/ajplung.00158.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/L841    most recent
00158.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, K. A
Right arrow Articles by Rodman, D. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, K. A
Right arrow Articles by Rodman, D. M
Submitted on April 11, 2005
Accepted on December 4, 2005

BMP signaling controls PASMC KV channel expression in vitro and in vivo

Katharine A Young1*, Charles Ivester1, James West1, Michelle Carr1, and David M Rodman1

1 Center for Genetic Lung Disease, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA

* To whom correspondence should be addressed. E-mail: katharine.young{at}uchsc.edu.

Bone morphogenetic proteins (BMPs) have been implicated in the pathogenesis of familial pulmonary arterial hypertension. The type-2 receptor (BMPR2) is required for recognition of all BMPs. Transgenic mice with a smooth muscle cell-targeted mutation in this receptor (SM22-tet-BMPR2delx4+) developed increased pulmonary artery pressure, associated with a modest increase in arterial muscularization, after two months of transgene activation (39). In the present study, we show that these transgenic mice developed increased RV pressures after only one week of transgene activation, without significant remodeling of the vasculature. We then tested the hypothesis that the increased pulmonary artery pressure due to loss of BMPR2 signaling was mediated by reduced KV channel expression. There was decreased expression of KV1.1, KV1.5, and KV4.3 mRNA isolated from whole lung. Western blot confirmed decreased KV1.5 protein in these lungs. Human pulmonary artery smooth muscle cells (PASMC) treated with recombinant BMP2 had increased KV1.5 protein and macroscopic KV current density, which was blocked by anti-KV1.5 antibody. In vivo, nifedipine, a selective L-type Ca++ channel blocker, reduced RV systolic pressure in these dominant-negative BMPR2 mice to levels seen in control animals. This suggests that activation of L-type Ca++ channels caused by reduced KV1.5 mediates increased pulmonary artery pressure in these animals. These studies suggest that BMP regulates KV channel expression and that loss of this signaling pathway in PASMC through a mutation in BMPR2 is sufficient to cause pulmonary artery vasoconstriction.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L744 - L755.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Archer, M. Gomberg-Maitland, M. L. Maitland, S. Rich, J. G. N. Garcia, and E. K. Weir
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H570 - H578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Laudi, S. Trump, V. Schmitz, J. West, I. F. McMurtry, H. Mutlak, U. Christians, J. Weimann, U. Kaisers, and W. Steudel
Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L630 - L638.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Hagen, K. Fagan, W. Steudel, M. Carr, K. Lane, D. M. Rodman, and J. West
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1473 - L1479.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Tada, S. Majka, M. Carr, J. Harral, D. Crona, T. Kuriyama, and J. West
Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1556 - L1563.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Case, D. Irwin, C. Ivester, J. Harral, K. Morris, M. Imamura, M. Roedersheimer, A. Patterson, M. Carr, M. Hagen, et al.
Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L154 - L164.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Fantozzi, O. Platoshyn, A. H. Wong, S. Zhang, C. V. Remillard, M. R. Furtado, O. V. Petrauskene, and J. X.-J. Yuan
Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L993 - L1004.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.